🇺🇸 FDA

Drug profile · INN

etanercept

BENEPALI

approved L04AB01
US status
approved
Patents linked
8
News articles
1

Quick answer

etanercept (BENEPALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN etanercept
Brand BENEPALI
Route SUBCUTANEOUS
Formulation VIAL
ATC code L04AB01

Related patents

Search patents →

Frequently asked questions

What is etanercept?

etanercept (BENEPALI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for etanercept?

BENEPALI is a marketed brand name for etanercept. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of etanercept?

etanercept has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.